NASS 2018 Annual Meeting
Tweet
Sessions
Speakers
Exhibitors
Products
Press Releases
Floor Plan
Buzz
Speakers
Jeffrey
Lotz, PhD
Jeffrey Lotz, PhD
Royalties: University of California (B); Stock Ownership: ISTO Technologies (<1%), Relievant Med Systems (<1%), Nocimed (9%), Simpirica (<1%), Aleeva Medical (<1%), SMC Biotech (<1%); Private Investments: Nocimed (<1%); Consulting: Applied Biomechanics (Amount not disclosed); Scientific Advisory Board: Relievant (Amount not disclosed), SMC Biotech (Amount not disclosed); Research Support - Investigator Salary: Orthofix (B, Paid directly to institution/employer); Research Support - Staff and/or Materials: Orthofix (E, Paid directly to institution/employer); Grants: Orthofix (E, Paid directly to institution/employer).
Sessions :
Section on Biologics and Basic Research: Injectable Biologic Therapies for Intervertebral Disc
Relievant Medsystems Presents: The Intracept® Procedure for the Relief of Chronic Low Back Pain
Home
Sessions
Speakers
Exhibitors
Products
Press Releases
Floor Plan
Tweet
Login
|
Back to top
ChirpE